De Silva Nishan M Insider Trades

Insider Trading History

Track insider trading activity for De Silva Nishan M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cartesian Therapeutics
Cartesian Therapeutics RNAC
Director
Holding Value $74.4k 11,366 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.6k 2,600 shares
$6.76
$6.55
Cartesian Therapeutics
Cartesian Therapeutics RNAC
Director
Holding Value $51.1k 7,800 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.7k 7,800 shares
$6.76
$6.55
Selecta Biosciences
Selecta Biosciences SELB
Director
Holding Value $0 0 shares
Last Trade
Nov 13, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$66.1k 75,000 shares
$0.88
$0.88
Selecta Biosciences
Selecta Biosciences SELB
Director
Holding Value $0 0 shares
Last Trade
Nov 13, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$35.2k 40,000 shares
$0.88
$0.88
Selecta Biosciences
Selecta Biosciences SELB
Director
Holding Value $0 0 shares
Last Trade
Nov 13, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$70.5k 80,000 shares
$0.88
$0.88
Selecta Biosciences
Selecta Biosciences SELB
Director
Holding Value $66.1k 75,000 shares
Last Trade
Jan 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84.8k 75,000 shares
$1.13
$0.88
Selecta Biosciences
Selecta Biosciences SELB
Director
Holding Value $35.2k 40,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$132k 40,000 shares
$3.31
$0.88
Selecta Biosciences
Selecta Biosciences SELB
Director
Holding Value $6.17k 7,000 shares
Last Trade
Dec 02, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20.7k 7,000 shares
$2.96
$0.88
Selecta Biosciences
Selecta Biosciences SELB
Director
Holding Value $70.5k 80,000 shares
Last Trade
Jun 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$366k 80,000 shares
$4.57
$0.88
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Vp, Finance & Strategy And CFO
Holding Value $10.2M 43,220 shares
Last Trade
May 14, 2015 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.76M 20,938 shares
$84.12
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Vp, Finance & Strategy And CFO
Holding Value $5.26M 22,282 shares
Last Trade
May 14, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.76M 20,938 shares
$83.84
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Vp, Finance & Strategy And CFO
Holding Value $5.68M 24,062 shares
Last Trade
May 14, 2015 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.76M 20,938 shares
$84.12
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Vp, Finance & Strategy And CFO
Holding Value $5.55M 23,546 shares
Last Trade
May 13, 2015 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.02M 12,148 shares
$83.81
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Vp, Finance & Strategy And CFO
Holding Value $5.26M 22,282 shares
Last Trade
May 13, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$980k 11,757 shares
$83.32
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Vp, Finance & Strategy And CFO
Holding Value $8.12M 34,430 shares
Last Trade
May 13, 2015 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.02M 12,148 shares
$83.81
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Vp, Finance & Strategy And CFO
Holding Value $8.03M 34,039 shares
Last Trade
May 13, 2015 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$985k 11,757 shares
$83.81
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Vp, Finance & Strategy And CFO
Holding Value $5.26M 22,282 shares
Last Trade
May 13, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.01M 12,148 shares
$83.23
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Vp, Finance & Strategy And CFO
Holding Value $15.1M 64,029 shares
Last Trade
May 13, 2015 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$985k 11,757 shares
$83.81
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Vp, Finance & Strategy And CFO
Holding Value $17.9M 75,786 shares
Last Trade
May 12, 2015 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.2M 14,214 shares
$84.14
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Vp, Finance & Strategy And CFO
Holding Value $8.42M 35,694 shares
Last Trade
May 12, 2015 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$783k 9,306 shares
$84.14
$235.91

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up